GPT and metabolic disease: Our findings suggest that pre-infection indicators of metabolic disorders, elevated A1C and blood glucose levels, liver enzymes ALT and AST >40 and a comorbidity of PCOS in women may be useful predictors of susceptibility to severe COVID-19, even in younger patients.